Tuberculosis infections of the central nervous system

Central Nervous System Agents in Medicinal Chemistry

Volumn 11, Issue 4, 2011, Pages 321-327

  Bartzatt, Ronald ^a  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Meningitis; Mycobacterium; Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ABNORMAL BEHAVIOR; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ABSCESS; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBROSPINAL FLUID; COMA; DRUG PENETRATION; FATALITY; HUMAN; MENTAL DISEASE; MILIARY TUBERCULOSIS; MULTIPLE ORGAN FAILURE; MYCOBACTERIUM TUBERCULOSIS; PARALYSIS; SEIZURE; TUBERCULOMA; TUBERCULOUS MENINGITIS;

EID: 84855815944     PISSN: 18715249     EISSN: 18756166     Source Type: Journal    
DOI: 10.2174/1871524911106040321     Document Type: Article

References (52)

1. Swartz, M. Meningitis: bacterial, viral and other. Saunders Elsevier: Philadelphia, 2007.
2. [UpToDate. Central nervous system tuberculosis. http://www.uptodate.com/contents/central-nervous-systemtuberculosis (Accessed October 13, 2011).
3. al-Deeb, S.; Yaqub, B.; Sharif, H.; Motaery, K. Neurotuberculosis: a review. Clin. Neurol. Neuroserg., 1992, 94(suppl S30), 30-41.
4. Be, N.; Kim, K.; Bishai, W.; Jain, S. Pathogenesis of central nervous system tuberculosis. Curr. Mol. Med., 2009, 9, 94-99.
5. Yaramis, A.; Gurkan, F.; Elevli, M.; Soker, M.; Haspolat, K.; Kirbas, G. Central nervous system tuberculosis in children: a review of 214 cases. Pediatrics, 1998, 102(5), 1-5.
6. Figaji, A.; Fieggen, A. The neurosurgical and acute care management of tuberculous meningitis: evidence and current practice. Tuberculosis, 2010, 90(6), 393-400.
7. [Marais, S.; Thwaites, G.; Schoeman, J.; Torok, M.E.; Misra, U.K.; Prasad, K.; Donald, P.R. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect. Dis., 2010, (11), 803-812.
8. Jacobs, R.; Sunakom, P.; Chotpitayasunonah, T.; Pope, S.; Kelleher, K. Intensive short course chemotherapy for tuberculous meningitis. Pediatr. Infect. Dis. J., 1992, 11(3), 194-198.
9. Vinnard, C.; Winston, C.; Willeyto, E.; MacGregor, R.R.; Bisson, G.P. Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ, 2010, 341, c4451.
10. Nagarathna, S.; Rafi, W.; Veenakumari, H.; Mani, R.; Satischandra, P.; Chandramuki, A. Drug susceptibility profiling of tuberculous meningitis. Int. J. Tuberc. Lung Dis., 2008, 12(1), 105-107.
11. Farinha, N.; Razali, K.; Holzel, H.; Morgan, G.; Novelli, V.M. Tuberculosis of the central nervous system in children; a 20-year survey. J. Infect., 2000, 41(1), 61-68.
12. Sutlas, P.; Unal, A.; Forta, H.; Senol, S.; Kirbas, D. Tuberculous meningitis in adults: review of 61 cases. Infection, 2003, 31(6), 387-391.
13. Jasmer, R.M.; Nahid, P.; Hopewell, P.C. Clinical practice. Latent tuberculosis infection. N. Eng. J. Med., 2002, 347(23), 1860-6.
14. th edition. Saunders Elsevier: New York, 2007.
15. Golden, M.P.; Vikram, H.R. Extrapulmonary tuberculosis: an overview. Am. Fam. Phys., 2005, 72(9), 1761-8.
16. rd ed. Saunders Elsevier: Philadelphia, 2007.
17. Swartz, M.N. Cecil Medicine, Meningitis: bacterial, viral, and other. 23rd ed. Saunders Elsevier: Philadelphia, 2007.
18. Garg, R.K. Tuberculosis of the central nervous system. Postgrad. Med. J., 1999, 75(881), 133-140.
19. Katti, M.K. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med. Sci. Monit., 2004, 10(9), RA215-229.
20. Pando, R.H. Modelling of cerebral tuberculosis: hope for continuous research in solving the enigma of the bottom billion's disease. Malaysian J. Med. Sci., 2011, 18(1), 12-15.
21. Tsenova, L.; Sokol, K.; Freedman, V.H.; Kaplan, G. A combination of thalidomide plus antibiotics protect rabbits from mycobacterial meningitis-associated death. J. Infect. Dis., 1998, 177(6), 1563-1572.
22. Tsenova, L.; Bergtold, A.; Freedman, V.H.; Young, R.A.; Kaplan, G. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc. Natl. Acad. Sci. USA, 1999, 96(10), 5657-5662.
23. van Well, G.T.; Wieland, C.W.; Florquin, S.; Roord, J.J.; van der Poll, T.; van Furth, A.M. A new murine model to study the pathogenesis of tuberculous meningitis. J. Infect. Dis., 2007, 195(5), 694-697.
24. Wu, H.S.; Kolonoski, P.; Chang, Y.Y.; Bermudez, L.E. Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice. Infect. Immun., 2000, 68(5), 2979-2984.
25. Bolin, C.A.; Whipple, D.L.; Khanna, K.V.; Risdahl, J.M.; Peterson, P.K.; Molitor, T.W. Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J. Infect. Dis., 1997, 176(6), 1559-1566
26. DeVincenzo, J.P.; Beming, S.E.; Peloguin, C.A.; Husson, R.N. Multidrug-resistant tuberculosis meningitis: clinical problems and concentrations of second-line antituberculous medications. Ann. Pharmcother., 1999, 33(11), 1184-8.
27. Banerjee, R.; Schecter, G.F.; Flood, J.; Porco, T.C. Extensively drug-resistant tuberculosis: new strains, new challenges. Expert Rev. Anti. Infect. Ther., 2008, 6(5), 713-24.
28. Vinnard, C.; Winston, C.A.; Wileyto, E.P.; MacGregor, R.R., Bisson, G.P. Isoniazid-resistant tuberculosis meningitis, United States, 1993-2005. Emerg. Infect. Dis., 2011, 17(3), 539-42.
29. Patel, V.B.; Padayatchi, N.; Bhigjee, A.; Allen, J.; Bhagwan, B.; Moodley, A.A.; Mthiyane, T. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin. Infect. Dis., 2004, 38(6), 851-56.
30. Thwaites, G.; Chau, T.; Mai, N.T.; Drobniewski, F.; McAdam, K.; Farrar, J. Tuberculosis meningitis. J. Neurol. Neurosurg. Psychiatry, 2000, 68, 289-99.
31. Sutherland, I.; Springett, V.H. Effectiveness of BCG vaccination in England. Tubercle, 1987, 68(2), 81-92.
32. Christensen, A.S.; Andersen, A.B.; Thomsen, V.O.; Andersen, P.H. Johansen, I.S. Tuberculous meningitis in Denmark: a review of 50 cases. BMC Infect. Dis., 2011,11, 47.
33. Byrd, T.F.; Davis, L.E. Multidrug-resistant tuberculous meningitis. Curr. Neurol. Neurosci. Rep., 2007, 7(6), 470-5.
34. Padayatchi, N.; Bamber, S.; Dawood, H.; Bobat, R. Multidrugresistant tuberculous meningitis in children in Durban, South Africa. Pediatr. Infect. Dis. J., 2006, 25(2), 147-50.
35. Schaaf, H.S.; Moll, A.P.; Dheda, K. Multidrug-and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children. Clin. Chest Med., 2009, 30(4), 667-83.
36. Cherian, A.; Thomas, S.V. Central nervous system tuberculosis. Afr. Health Sci., 2011, 11(1), 116-27.
37. Galimi, R. Extrapulmonary tuberculosis: tuberculous meningitis new developments. Eur. Rev. Med. Pharmacol. Sci., 2011, 15(4), 365-89.
38. Kumar, R.; Pandey, C.K.; Bose, N.; Sahay, S. tuberculous brain abscess: clinical presentation, pathophysiology and treatment (in children). Childs Nerv. Syst., 2002, 18(3-4), 118-23.
39. Gump, W.C.; Summers, L.E.; Walsh, J.W. Tuberculosis infection presenting as brain abscess in an immunocompromised host. J. La. State Med. Soc., 2006, 158(6), 292-5.
40. Megarbane, B.; Lebrun, L.; Marchal, P.; Axler, O.; Brivet, F.G. Fatal Mycobacterium tuberculosis brain abscess in an immunocompetent patient. Scand. J. Infect. Dis., 2000, 32(6), 702-3.
41. Ropper, A.H.; Adams, R.D.; Brown, R.F.; Maurice, V. Adams and Victor's principles of neurology. McGraw-Hill Medical Pub Division: New York, 2005.
42. Sanchetee, P. Stroke and central nervous system infections. J. Indian Med. Assoc., 2009, 107(6), 372-7.
43. Misra, U.K.; Kalita, J.; Maurya, P.K. Stroke in tuberculous meningitis. J. Neurol. Sci., 2011, 303(1-2), 22-30.
44. Takeoka, M.; Takahashi, T. Infectious and inflammatory disorders of the circulatory system and stroke in childhood. Curr. Opin. Neurol., 2002, 15(2), 159-64.
45. Lan, S.H.; Chang, W.N.; Lu, C.H.; Lui, C.C.; Chang, H.W. Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis. QJM, 2001, 94(5), 247-53.
46. Sheu, J.J.; Chiou, H.Y.; Kang, J.H.; Chen, Y.H.; Lin, H.C. Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study. Stroke, 2010, 41, 244-49.
47. Leiguarda, R.; Berthier, M.; Starkstein, S.; Nogues, M.; Lylyk, P. Ischemic infarction in 25 children with tuberculous meningitis. Stroke, 1988, 19(2), 200-4.
48. Anderson, N.E.; Somaratne, J.; Mason, D.F.; Holland, D.; Thomas, M.G. Neurological and systemic complications of tuberculous meningitis and its treatment at Auckland City Hospital, New Zealand. J. Clin. Neurosci., 2010, 17(9), 1114-1118.
49. Verma, R.; Sharma, P. Lateral medullary syndrome due to brain stem tuberculoma. J. Assoc. Phys. India, 2011, 59, 382-4.
50. Cole, E.; Cook, C. Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies. Am. J. Infect. Control, 1998, 26 (4), 453-64.
51. Nicas, M.; Nazaroff, W.W.; Hubbard, A. Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J. Occup. Environ. Hyg., 2005, 2(3), 143-54.
52. Behr, M.A.; Warren, S.A.; Salamon, H.; Hopwell, P.C.; Ponce de Leon, A.; Daley, C.L.; Small, P.M. Transmission of Mycobacterium tuberculosis from patients smear-negative for acidfast bacilli. Lancet, 1999, 353(9151), 444-9.